Insider Stock Trading History of Greene Barry E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Greene Barry E since year 2005. The trader's CIK number is 1291963. At the time of this reporting, Greene Barry E is the President of Alnylam Pharmaceuticals, Inc. . (stock ticker symbol ALNY). See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .

Note that in the past Greene Barry E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Greene Barry E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-02 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 85,316 21.35 1,821,496
2017-10-02 ALNY Alnylam Pharmaceuticals, Inc. Sale 85,316 125.00 10,664,500
2017-09-20 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 76,815 31.39 2,411,222
2017-09-21 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 11,844 12.88 152,550
2017-09-20 ALNY Alnylam Pharmaceuticals, Inc. Sale 76,815 100.00 7,681,500
2017-08-01 ACOR Acorda Therapeutics Inc Option Ex 10,000 18.21 182,100
2017-08-01 ACOR Acorda Therapeutics Inc Sale 10,000 21.57 215,700
2017-02-09 ACOR Acorda Therapeutics Inc Sale 723 22.65 16,375
2017-02-09 ACOR Acorda Therapeutics Inc Option Ex 723 22.13 15,999
2017-01-03 ACOR Acorda Therapeutics Inc Sale 3,017 19.26 58,113
2017-01-03 ACOR Acorda Therapeutics Inc Option Ex 3,017 15.91 48,000
2016-03-24 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 16,540 8.12 134,304
2015-08-04 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 26,972 19.03 513,277
2015-05-26 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 67,379 13.12 884,012
2015-05-26 ALNY Alnylam Pharmaceuticals, Inc. Sale 67,379 125.00 8,422,375
2015-04-02 KPTI Karyopharm Therapeutics Inc. Buy 3,000 29.31 87,939
2014-12-19 ALNY Alnylam Pharmaceuticals, Inc. Sale 11,200 100.00 1,120,000
2014-12-22 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 1,000 13.12 13,120
2014-11-17 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 33,200 6.78 225,096
2014-11-17 ALNY Alnylam Pharmaceuticals, Inc. Sale 33,200 90.97 3,020,104
2014-11-11 ALNY Alnylam Pharmaceuticals, Inc. Sale 11,100 100.00 1,110,000
2014-11-11 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 11,100 6.78 75,258
2014-02-03 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 19,500 6.78 132,210
2013-12-17 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 11,200 6.78 75,936
2013-05-28 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 22,822 .95 21,680
2013-05-28 ALNY Alnylam Pharmaceuticals, Inc. Sale 22,822 30.00 684,660
2013-03-14 ALNY Alnylam Pharmaceuticals, Inc. Sale 24,058 25.00 601,450
2013-03-14 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 24,058 .95 22,855
2013-03-08 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 24,000 .95 22,800
2013-03-08 ALNY Alnylam Pharmaceuticals, Inc. Sale 24,000 24.43 586,272
2012-02-21 ALNY Alnylam Pharmaceuticals, Inc. Buy 1,860 10.75 19,995
2012-01-09 ALNY Alnylam Pharmaceuticals, Inc. Buy 567 8.80 4,991
2011-12-12 ALNY Alnylam Pharmaceuticals, Inc. Buy 699 7.15 4,995
2011-11-14 ALNY Alnylam Pharmaceuticals, Inc. Buy 704 7.09 4,994
2011-10-11 ALNY Alnylam Pharmaceuticals, Inc. Buy 742 6.73 4,995
2008-08-13 ALNY Alnylam Pharmaceuticals, Inc. Sale 35,440 33.93 1,202,372
2008-08-13 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 30,889 .95 29,344
2007-10-24 ALNY Alnylam Pharmaceuticals, Inc. Sale 21,700 30.79 668,186
2007-10-24 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,580 31.13 329,387
2007-10-24 ALNY Alnylam Pharmaceuticals, Inc. Sale 5,220 31.63 165,119
2006-10-31 ALNY Alnylam Pharmaceuticals, Inc. Sale 12,500 20.71 258,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greene Barry E (President of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.